PathAI Announces Research Presentations at the Society for Immunotherapy of Cancers 38th Annual Meeting
–News Direct–
PathAI, a leading technology company which combines AI-powered pathology solutions with end-to-end central pathology and histology services, today announced it will present research underscoring the efficacy of PathExplores human interpretable features (HIFs) through three poster presentations at the Society for Immunotherapy of Cancers 38th Annual Meeting on November 1-5 in San Diego, CA. The posters showcase how PathExplore provides high-resolution characterization of the tumor microenvironment (TME) through a standardized panel of HIFs derived from H&E whole slide images across multiple cancer types. Additionally, Incendia Therapeutics will present two posters reporting results that were generated utilizing PathExplore.
Building upon past publications and presenta...
